The Operating Theatre Journal - Flipbook - Page 10
connected medical device will now be available in the United States for medical use to measure
body temperature in pa琀椀ents for diagnos琀椀c or therapeu琀椀c purposes (clinical research, infec琀椀ology,
oncology, internal medicine).
As a marker of infec琀椀on, hyper or hypothermia, body temperature is an essen琀椀al indicator in
diagnosing a pa琀椀ent’s state of health, and con琀椀nuous, accurate measurement of this parameter is vital
in the monitoring of pa琀椀ents in cri琀椀cal situa琀椀ons. However, un琀椀l now, only a few restric琀椀ve devices,
such a rectal or oesophageal probes, have been able to combine an
accurate and con琀椀nuous monitoring of core temperature. To meet this
need, French MedTech BodyCAP, based in Caen (Calvados), has
developed the eCel ius Medical System, a Class II medical dev
t
enables this measurement to be carried out in real 琀椀me using a small
miniaturised electronic capsule, which is less than 2cm long, that can
be swallowed (see photo opposite).
This condensed technology communicated in real 琀椀me at a frequency of 30 seconds with a dedicated
monitor, the eViewer Medical, which records the data autonomously and triggers alerts if the threshold
is exceeded. The temperature is accurate to within ±0.1°C of the human physiological range between
41°C, and the communica琀椀on protocol guarantees data security.
French MedTech BodyCAP launches its “eCelsius Medical System”, a connected
ingestible thermometerExper琀椀se
for medical
applications in the United States.
in assembling the device and op琀椀mising communica琀椀on
for medical
applica琀椀ons
BodyCAP,a aconnected
French MedTechinges琀椀ble
company, has thermometer
The temperature is accurate
to within ±0.1°C
e
Precise, con琀椀nuous, non invasive body temperature monitoring
This medical device can be used in both research and clinical applica琀椀ons. The major areas currently
taken another step forward with
the approval ofelectronics
the human
physiological
between
area rise
encapsulated
inrange
a biocompa琀椀ble
• Infec琀椀ology: Detec琀椀on of the onset
of an infec琀椀on through
in temperature. The “eCel
ius
of its “eCelsius Medical System”Medical
connected
36-41°C,
and the communication protocol
System” secures pa琀椀ent
monitoring.
• Oncology: Early detec琀椀on of fever peaks in pa琀椀ents undergoing chemotherapy, reducing the
medical device by the US Food
and Drug
guarantees data security.
琀椀me taken by medical sta昀昀 to intervene.
the
Administration (FDA). This thermometer,
pa琀椀ent, continuous,
guaranteeing
an opera琀椀onal
life
Precise,
non-invasive
body
integrated into
a
capsule
that
is
simply
, a French MedTech company, has
taken another
step forward
with the
approval of its
temperature
monitoring
corresponding
to
the
individual
characteris琀椀cs
of
swallowed, enables a continuous and accurate
ius
Medical
System”
connected
medical
device
by
the
US
Food
and
Drug
Administra琀椀on
(FDA).
gastrointes琀椀nal mo琀椀lity (on average 2 +/
s
measurement of core body temperature This
medical device can be used in both
throughout
the gastrointestinal
transit into
until itaiscapsule
and
up
to
6
days).
Every
aspect
of
this
technology
This thermometer,
integrated
that
is
simply
swallowed,
enables
a
con琀椀nuous
and
research and clinical applications. The major
expelled.
Already
widely
adopted
in
the
sports
has
been
studied
and
tested
to
ensure
op琀椀mum
areas currently
targeted are:
accurate measurement of
body temperature
throughout
the gastrointes琀椀nal transit un琀椀l it is
and military sectors, the eCelsius Medical
performance and eliminate any risk of blockage or
expelled.
Already
widely
adopted
in
the
sports
and
military
sectors,
the eCel
System connected medical device will now be
• Infectiology:
intoxica琀椀on. Detection of the onset of an
available
in themedical
United States
medical
infection
through
a rise
in temperature.
The
connected
deviceforwill
now use
be available
in the
United
States
for medical
use to measure
The
company
produces all this
its connected
capsules
to measure core body temperature in patients
“eCelsius
Medical
System”
secures
patient
The
result
of
a
fusion
between
research
into
human
physiology
and microelectronics,
body temperature in pa琀椀ents for diagnos琀椀c or therapeu琀椀c purposes (clinical research,
infec琀椀ology,
in France
and generates 90% of its sales
for diagnostic or therapeutic purposes (clinical
monitoring.
capsule has been used since 2016 in military and sports applica琀椀ons, for detailed analysis of
internationally.
oncology,
internal medicine).
research,
infectiology,
oncology, internal
uring marathons and the Olympic Games etc. 90,000 capsules have been used
• Oncology: Early detection of fever peaks in
medicine).
Available from January 2024 for medical use,
over the undergoing
last 5 years. chemotherapy,
The company produces
all its capsules in France and generates 90% of its sales
patients
As a marker of infec琀椀on, hyper or hypothermia,
body temperature
isreducing
an essen琀椀al
the indicator
amount ofinsales should rapidly reach
interna琀椀onally.
the
time taken by medical staff to intervene.
As a marker of infection, hyper- or hypothermia,
several tensisof
thousands of units per year.
diagnosing
a
pa琀椀ent’s
state
of
health,
and
con琀椀nuous,
accurate
measurement
of
this
parameter
vital
body temperature is an essential indicator
The
next
regulatory
step inreach
the United
States
Available
from
January
2024
for
medical
use,
the
amount
of
sales
should
rapidly
several tens
of
Expertise
in
assembling
the
device
and
the monitoring
of pa琀椀ents
in cri琀椀cal
in indiagnosing
a patient’s
state of
health, situa琀椀ons. However, un琀椀l now, only a few restric琀椀ve devices,
is to obtain FDA approval for the entire device,
thousandscommunication
of units per year.
optimising
and
continuous,
accurate
measurement
of
such a rectal or oesophageal probes, have been able to combine an
including the data transmission chain to the
this parameter is vital in the monitoring of Designed
bystep
theinBodyCAP
teams,
The
nextin-house
regulatory
the United
Statesthe
is to obtain
FDA Cybersecurity
approval for theisen琀椀re
including
cloud.
onedevice,
of BodyCAP’s
accurate
and
con琀椀nuous
monitoring
of
core
temperature.
To
meet
this
patients in critical situations. However, until
electronics
are encapsulated
a biocompatible
priorities,
this security
is
the data transmission
chain tointhe
cloud. Cybersecurity
is one of and
BodyCAP’s
priori琀椀es,requirement
and this security
now,
only French
a few restrictive
suchbased
a
need,
MedTech devices,
BodyCAP,
in Caen
has
material
and (Calvados),
sealed
in a medical-grade
PVC
fully
integrated
into the development of the
requirement
is
fully
integrated
into
the
development
of
the
device.
rectal
or oesophageal
probes,
haveSystem,
been acapsule.
capsule
developed
the eCel ius
Medical
Class II The
medical
devis eliminated naturally by device.
able to combine an accurate and continuous the patient,
guaranteeing
andevice
operational
life use is a major step in the company’s growth It is the
“The
approval
of
our
for medical
“The approval of our device for medical use
enables
this
measurement
to
be
carried
out
in
real
琀椀me
using
a small
monitoring of core temperature. To meet this corresponding to the individual
characteristics
culmina琀椀on of our investment
in R&D and our
monitoring
is exper琀椀se
a majorinstep
in thephysiological
company’s parameters
growth It
need,
French
MedTech
BodyCAP,
based
in
miniaturised electronic capsule, which is less
thanmore
2cmaccurately
long,
that
can
of gastrointestinal
motility
(oninaverage
2 For
+/- pa琀椀ents, the use of this device makes treatment more
in
vivo,
real
琀椀me.
is
the
culmination
of
our
investment in R&D
Caen (Calvados), has developed the eCelsius 1.5 days and up to 6 days). Every aspect of
be swallowed (see photo opposite).
e昀昀ec琀椀ve in several types of pathology, and weand
willour
con琀椀nue
to provide
new solu琀椀ons
to op琀椀mise
expertise
in monitoring
physiological
Medical System, a Class II medical device that
this technology has been studied and tested
parameters
more accurately
in vivo,
in real
care
and
prevent
complica琀椀ons”,
oncludes
Sébas琀椀en
MOUSSAY,
co
founder
and
Chairman
and
enables this measurement to be carried out in
to ensure optimum performance and eliminate
This
condensed
technology
communicated
in real 琀椀me at a frequency of 30 seconds with
dedicated
time.a For
patients, the use of this device
real
time
using a small
miniaturised
electronic
any risk of blockage or intoxication.
treatment more effective in several
capsule,
which
less thanMedical,
2cm long,which
that can
monitor,
theiseViewer
records the data autonomously and triggers alertsmakes
if the threshold
types of pathology, and we will continue to
The result of a fusion between research into
be swallowed (see photo opposite).
is exceeded. The temperature is accurate to within ±0.1°C of the human physiologicalprovide
range between
new solutions to optimise care and
human physiology and microelectronics, this
About BodyCAP
prevent complications”, concludes Sébastien
41°C, andtechnology
the communica琀椀on
protocol
guarantees
data has
security.
This condensed
communicated
in
connected
capsule
been used since 2016 in
MOUSSAY,
co-founder
Chairman.
real time at a frequency of 30 seconds with
military and
sports applications,
for detailed
is a company
that designs, develops,
and markets
wireless and
miniaturisedand
physiological
measurement
a dedicated monitor, the eViewer Medical, analysis
hypothermia
episodes
duringexper琀椀se
BodyCAP.
solu琀椀ons.of
Founded
in 2011, BodyCAP
has developed
in ultra miniaturised systems, embedded so昀琀ware
which records the data autonomously and
marathons
and
the OlympicInGames
etc.Bo90,000
+33 (0) 2ius
61Performance,
53 03 29 contact@bodycap.io
and wireless
communica琀椀on.
par琀椀cular,
a communica琀椀ng electronic
triggers
alerts
if the threshold
is exceeded.
capsules
havemonitoring
been
used over thecore
lasttemperature
5 years. measurement.
https://www.bodycap-medical.com
Precise,
con琀椀nuous,
non invasive
body temperature
capsule dedicated
to gastrointes琀椀nal
professional, clinical, and medical sectors. h琀琀ps://www.bodycap
When responding to articles please quote ‘OTJ’
This medical device can be used in both research and clinical applica琀椀ons. The major areas currently
•
•
Infec琀椀ology: Detec琀椀on of the onset Press
of anContacts
infec琀椀on through a rise in temperature. The “eCel ius
Medical System” secures pa琀椀ent monitoring.
Valen琀椀ne Mar琀椀n valen琀椀ne.mar琀椀n@prpa.fr 06 32 29 43 82
Oncology: Early detec琀椀on of fever peaks
in pa琀椀ents undergoing chemotherapy, reducing the
琀椀me taken by medical sta昀昀 to intervene.
+33 (0) 2 61 53 03 29
contact@bodycap.io
10
THE OPERATING THEATRE JOURNAL
www.otjonline.com